Publication | Closed Access

2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial

Non-pharmacological InterventionDiabetes ManagementHealth PolicyCardiovascular Disease2-Year EfficacyDiabetesType 2PharmacotherapyNon-inferiority TrialDiabetes MellitusPublic HealthMedicine